US Patent 11945874 Anti-human CD52 immunoglobulins
Patent 11945874 was granted and assigned to Genzyme on April, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 3, 2021
0
Date of Patent
April 2, 2024
0
Patent Applicant
Patent Application Number
17191440
0
Patent Citations
Patent Inventor Names
Bruce L. Roberts
0
Srinivas Shankara
0
William M. Siders
0
William Harold Brondyk
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11945874 Anti-human CD52 immunoglobulins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
